• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELUTIA INC. ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE; CANGAROO RM ANTIBACTERIAL ENVELOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELUTIA INC. ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE; CANGAROO RM ANTIBACTERIAL ENVELOPE Back to Search Results
Model Number CMCV-124-LRG
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hematoma (1884)
Date of Event 06/06/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Elutia lhr review completed on 08/08/2025 for lot m25a1005 and subassembly lot m24n1343.No discrepancies in the manufacturing process were noted in either batch record during review.It is noted that per the instructions for use (ifu - art20837 rev.A, ifu elupro antibiotic-eluting bioenvelope) provided with the finished elupro device, "hematoma" is listed within the potential complications associated with device usage.Hematoma is a known complication with the implant of a cardiac implantable device for cardiac surgical procedure.
 
Event or Problem Description
Email was received from the elutia representative regarding a patient in an elutia registry study.It was reported that on (b)(6) 2025, the patient had a pocket revision with a pacemaker implant along with the implant of a large elupro antibiotic-eluting bioenvelope (model cmcv-124-lrg, lot m25a1005).On 06/10/2025, the site became aware (patient onset (b)(6) 2025) that the patient developed a hematoma and was treated with oral antibiotics (doxycycline) and rivaroxaban (held 3 days).After (b)(6) 2025, the patient did not note any symptoms related to a hematoma.The site also noted that the patient did not have any existing conditions or comorbidities which could have contributed to the hematoma.No further details are available regarding this event but if elutia receives more information, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUPRO ANTIBIOTIC-ELUTING BIOENVELOPE
Common Device Name
CANGAROO RM ANTIBACTERIAL ENVELOPE
Manufacturer (Section D)
ELUTIA INC.
1100 old ellis road
ste. 1200
roswell 30076
Manufacturer (Section G)
ELUTIA INC.
1100 old ellis road
ste. 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
roswell, GA 30076
4705144023
MDR Report Key22777214
Report Number3005619880-2025-00007
Device Sequence Number9185090
Product Code FTM
UDI-Device Identifier00859389005348
UDI-Public00859389005348
Combination Product (Y/N)Y
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K233991
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/29/2025
Device Model NumberCMCV-124-LRG
Device Lot NumberM25A1005
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/15/2025
Initial Report FDA Received Date08/11/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexFemale
-
-